Addressing superbug resistance with phage therapy

August 16, 2017, Monash University
Addressing superbug resistance with phage therapy
Credit: Monash University

International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug resistant bacterial infections.

The latest research, published in Antimicrobial Agents & Chemotherapeutics has wide implications for antibiotic resistance, which the World Health Organization has described as a major threat to public health.

One of the study's authors, Dr Jeremy Barr from the Monash School of Biological Sciences, said that antibiotics can no longer be solely relied upon to halt the spread of .

"Last year we saw a patient die in the USA from a bacterial infection resistant to all antibiotics. 'Pan-resistant' strains of bacterial infection are inevitable," Dr Barr said.

Dr Barr's lab at Monash University studies bacteriophage - specialist viruses that only infect and kill bacteria - and investigates their role and function in the human .

Bacteriophage (or phage for short) are the most abundant and diverse microbe found in the body. Phages control and manipulate bacterial populations, prevent infection and disease and have important roles in regulating the microbiome and body that have not yet been fully elucidated.

The latest research, published in the prestigious Antimicrobial Agents & Chemotherapeutics,follows the remarkable case of a 69-year-old diabetic in the US who was treated successfully with bacteriophages after being infected with a life-threatening multidrug-resistant strain of Acinetobacter baumannii.

The study is significant because it is the first time bacteriophage therapy has been used in the USA to treat a patient who had an antibiotic-resistant, blood stream infection.

"Antibiotics were no longer working, and this infection would have very likely killed him had we not intervened."

Explore further: Antibiotics are not always the answer

More information: Robert T. Schooley et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection, Antimicrobial Agents and Chemotherapy (2017). DOI: 10.1128/AAC.00954-17

Related Stories

Antibiotics are not always the answer

July 7, 2017
The discovery of penicillin in 1928 was heralded as a medical miracle. As one of the first antibiotics, it could cure patients of potentially deadly bacterial illnesses, such as scarlet fever, typhoid and pneumonia.

Scientists identify novel approach for bacteriophage treatment of Clostridium difficile infection

September 12, 2016
University of Leicester scientists have previously identified the potential of using a bacteriophage cocktail to eradicate Clostridium difficile infection (CDI) and in this research, using an insect model, they show that ...

Bacteriophages battle superbugs

July 18, 2013
IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

Bacteriophages cure bacterial infections

November 16, 2016
Phage therapy may be a solution to treating infections caused by antibiotic-resistant bacteria. Since 2013, researchers at the University of Helsinki in Finland have collected bacteriophages to combat antibiotic-resistant ...

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.